Combination therapy • P2 data • Clinical • PD(L)-1 Biomarker • MSi-H Biomarker • IO biomarker • Metastases
|
MSI (Microsatellite instability) • CD8 (cluster of differentiation 8)
|
PD-L1 expression • MSI-H/dMMR
|
Immunoscore®
|
Tecentriq (atezolizumab) • Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) • PolyPEPI 1018